4//SEC Filing
Borgeson Blake 4
Accession 0001601830-24-000160
CIK 0001601830other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 5:48 PM ET
Size
5.3 KB
Accession
0001601830-24-000160
Insider Transaction Report
Form 4
Borgeson Blake
Director
Transactions
- Sale
Class A Common Stock
2024-09-17$6.84/sh−11,447$78,333→ 7,109,875 total
Footnotes (2)
- [F1]This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $6.74 to $7.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0001856094
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 5:48 PM ET
- Size
- 5.3 KB